FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (BluePoint Laboratories)

View source ↗

Summary

FDA approves BluePoint Laboratories' supplemental application for Bupropion Hydrochloride under ANDA 076143, approving changes to the approved generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Seasonal Affective Disorder
• Smoking Cessation

Drugs mentioned

• Bupropion hydrochloride (Bupropion hydrochloride)

Snippet

SUPPL AP for BUPROPION HYDROCHLORIDE (BUPROPION HYDROCHLORIDE)